INMED PHARMACEUTICALS INC. Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months
INMED PHARMACEUTICALS INC. (INM) had Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months of $437.43 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths · last filed 2023-05-15
- 2023-03-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $437.43K.
- 2022-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $433.19K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months |
|---|---|
| 2023-03-31 | $437.43K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $433.19K 10-Q · filed 2023-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |